These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 893463)

  • 1. The thermal stability of a stabilized 17D yellow fever virus vaccine.
    Burfoot C; Young PA; Finter NB
    J Biol Stand; 1977; 5(3):173-9. PubMed ID: 893463
    [No Abstract]   [Full Text] [Related]  

  • 2. The development of an improved experimental yellow fever vaccine.
    Tannock GA; Wark MC; Hair CG
    J Biol Stand; 1980; 8(1):23-34. PubMed ID: 7400156
    [No Abstract]   [Full Text] [Related]  

  • 3. Stability of yellow fever vaccine.
    Monath TP
    Dev Biol Stand; 1996; 87():219-25. PubMed ID: 8854020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The thermal stability of yellow fever vaccines.
    Ishak R; Howard CR
    Mem Inst Oswaldo Cruz; 1990; 85(3):339-45. PubMed ID: 2134708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term storage studies with a new stabilised formulation of yellow fever virus vaccine.
    Finter NB; Burfoot C; Young PA; Ferris R
    Dev Biol Stand; 1976 Oct; 36():279-83. PubMed ID: 1030425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of stabilized yellow fever vaccine 17D at the time of the yellow fever epidemic in Burkina Faso in 1983].
    Saluzzo JF; Some L; Baudon D; Girault G; Lhuillier M; Kambire PA; Roux JF; Digoutte JP
    Bull Soc Pathol Exot Filiales; 1985; 78(4):536-40. PubMed ID: 4075474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thermostabilization of the lyophilized yellow fever vaccine 17-D. II. Pilot lots prepared under conditions of industrial production].
    Barme M; Vacher B; Ryhiner ML; Chabannier G
    J Biol Stand; 1987 Jan; 15(1):67-72. PubMed ID: 3558422
    [No Abstract]   [Full Text] [Related]  

  • 8. Stability of 17D yellow fever virus vaccine using different stabilizers.
    Adebayo AA; Sim-Brandenburg JW; Emmel H; Olaleye DO; Niedrig M
    Biologicals; 1998 Dec; 26(4):309-16. PubMed ID: 10403034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Stability of a new thermostable 17D yellow fever vaccine].
    Durand JP; Kollo B; Merlin M; Le Hesran JY; Josse R; Garrigue GP
    J Biol Stand; 1988 Jan; 16(1):1-7. PubMed ID: 3350820
    [No Abstract]   [Full Text] [Related]  

  • 10. Thermostability and efficacy in the field of a new, stabilized yellow fever virus vaccine.
    Georges AJ; Tible F; Meunier DM; Gonzalez JP; Beraud AM; Sissoko-Dybdahl NR; Abdul-Wahid S; Fritzell B; Girard M; Georges-Courbot MC
    Vaccine; 1985 Sep; 3(3):313-5. PubMed ID: 4060841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on the stability of 17D-204 yellow fever vaccine before and after stabilization.
    Sood DK; Aggarwal RK; Sharma SB; Sokhey J; Singh H
    Vaccine; 1993; 11(11):1124-8. PubMed ID: 8249431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
    Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
    Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thermal stability of lyophilized 17D yellow fever virus vaccine. I. Trial of protective substances].
    Barme M; Bronnert C
    J Biol Stand; 1984 Oct; 12(4):435-42. PubMed ID: 6526828
    [No Abstract]   [Full Text] [Related]  

  • 14. A clinical study of stabilized 17D strain live attenuated yellow fever vaccine.
    Moss-Blundell AJ; Bernstein S; Shepherd WM; Langford DT; Ferris R; Kelly A
    J Biol Stand; 1981 Oct; 9(4):445-52. PubMed ID: 7320025
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative clinical study of a new 17D thermostable yellow fever vaccine.
    Roche JC; Jouan A; Brisou B; Rodhain R; Fritzell B; Hannoun C
    Vaccine; 1986 Sep; 4(3):163-5. PubMed ID: 3532602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of yellow fever 17DD vaccine virus in primary culture of chicken embryo fibroblasts: yields, thermo and genetic stability, attenuation and immunogenicity.
    Freire MS; Mann GF; Marchevsky RS; Yamamura AM; Almeida LF; Jabor AV; Malachias JM; Coutinho ES; Galler R
    Vaccine; 2005 Mar; 23(19):2501-12. PubMed ID: 15752837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Process intensification of EB66® cell cultivations leads to high-yield yellow fever and Zika virus production.
    Nikolay A; Léon A; Schwamborn K; Genzel Y; Reichl U
    Appl Microbiol Biotechnol; 2018 Oct; 102(20):8725-8737. PubMed ID: 30091043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on yellow fever vaccine. II--Stability of the reconstituted product.
    Lopes Ode S; Guimarães SS; de Carvalho R
    J Biol Stand; 1988 Apr; 16(2):71-6. PubMed ID: 3372544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program.
    Collaborative Group for Studies with Yellow Fever Vaccine
    Vaccine; 2007 Apr; 25(16):3118-23. PubMed ID: 17316925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the nucleotide and deduced amino acid sequences of the structural protein genes of the yellow fever 17DD vaccine strain from Senegal with those of other yellow fever vaccine viruses.
    Jennings AD; Whitby JE; Minor PD; Barrett AD
    Vaccine; 1993; 11(6):679-81. PubMed ID: 8322493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.